0.75% 0.22

Agios Pharmaceuticals Inc (AGIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Agios Pharmaceuticals Inc-Aktie (AGIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	55.02% 19.97	12.88	12.46	8.726	10.73
Cost Of Revenue	11.91% 1.879	1.679	1.702	1.085	1.26
Gross Profit	61.49% 18.09	11.20	10.75	7.641	9.47
Operating Expenses	9.05% 139.67	128.07	137.81	114.27	134.51
Benefits Costs and Expenses	10.93% 129.02	116.31	139.51	115.36	116.13
Costs And Expenses	9.09% 141.54	129.75	139.51	115.36	135.77
Operating Income/Loss	4.03% -121.58	-116.87	-127.06	-106.63	-125.04
Income/Loss From Continuing Operations Before Tax	5.44% -109.06	-103.43	-112.02	-89.29	-105.40
Income Tax Expense/Benefit	-1.016	-	-	-	-8.876
Income/Loss From Continuing Operations After Tax	4.45% -108.04	-103.43	-112.02	-89.29	-96.52
Net Income/Loss	4.45% -108.04	-103.43	-112.02	-89.29	-96.52
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.78% 0.1258	58.14	57.93	57.46	0.0981
Diluted Average Shares	99.78% 0.1258	58.14	57.93	57.46	0.3079
Basic Earnings Per Share	3.93% -1.85	-1.78	-1.93	-1.55	-1.72
Diluted Earnings Per Share	3.93% -1.85	-1.78	-1.93	-1.55	-1.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.87

0.18%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$139.44

0.28%

ONC

$288.30

0.99%